Details for New Drug Application (NDA): 214856
✉ Email this page to a colleague
The generic ingredient in ENOXAPARIN SODIUM is enoxaparin sodium. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
Summary for 214856
Tradename: | ENOXAPARIN SODIUM |
Applicant: | Nanjing King-friend |
Ingredient: | enoxaparin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 214856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ENOXAPARIN SODIUM | enoxaparin sodium | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 214856 | ANDA | Meitheal Pharmaceuticals Inc. | 71288-426 | 71288-426-91 | 1 VIAL, MULTI-DOSE in 1 CARTON (71288-426-91) / 3 mL in 1 VIAL, MULTI-DOSE |
ENOXAPARIN SODIUM | enoxaparin sodium | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 214856 | ANDA | Meitheal Pharmaceuticals Inc. | 71288-426 | 71288-426-03 | 1 VIAL, MULTI-DOSE in 1 CARTON (71288-426-03) / 3 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Strength | 300MG/3ML (100MG/ML) | ||||
Approval Date: | Jun 14, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription